Xue‐cheng Bi
- Topics
- Signaling Pathways in Disease (8 papers)Peptidase Inhibition and Analysis (7 papers)Pediatric Urology and Nephrology Studies (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xue‐cheng Bi
28 papers receiving 654 citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 383
- Oncology 216
- Pulmonary and Respiratory Medicine 165
- Cancer Research 160
- Immunology 102
Countries citing papers authored by Xue‐cheng Bi
This map shows the geographic impact of Xue‐cheng Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue‐cheng Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue‐cheng Bi more than expected).
Fields of papers citing papers by Xue‐cheng Bi
This network shows the impact of papers produced by Xue‐cheng Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue‐cheng Bi. The network helps show where Xue‐cheng Bi may publish in the future.
Co-authorship network of co-authors of Xue‐cheng Bi
This figure shows the co-authorship network connecting the top 25 collaborators of Xue‐cheng Bi. A scholar is included among the top collaborators of Xue‐cheng Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue‐cheng Bi. Xue‐cheng Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 7 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 43 | |
| 7 | 18 | |
| 8 | 40 | |
| 9 | 43 | |
| 10 | 17 | |
| 11 | 12 | |
| 12 | 33 | |
| 13 | 22 | |
| 14 | 48 | |
| 15 | 11 | |
| 16 | 15 | |
| 17 | 18 | |
| 18 | 38 | |
| 19 | 87 | |
| 20 | 3 |
About Xue‐cheng Bi
Xue‐cheng Bi is a scholar working on Cancer Research, Immunology and Allergy and Urology, having authored 30 papers that have together received 667 indexed citations. Recurring topics across this work include Signaling Pathways in Disease (8 papers), Peptidase Inhibition and Analysis (7 papers) and Pediatric Urology and Nephrology Studies (4 papers). The work is most often cited by research in Cancer Research (160 citations), Oncology (216 citations) and Molecular Biology (383 citations). Xue‐cheng Bi has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Weide Zhong, Qi-Shan Dai, Zhaodong Han, Huichan He, Yongkang Ye, Guohua Zeng, Yuxiang Liang, Gang Zhu, Weijun Qin and Zhi‐Nan Chen. Their work appears in journals such as International Journal of Cancer, BioMed Research International and Endocrine Related Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.